These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 34294814)
1. Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia. Zahran AM; Shibl A; Rayan A; Mohamed MAEH; Osman AMM; Saad K; Mahmoud KH; Ghandour AMA; Elsayh KI; El-Badawy O Sci Rep; 2021 Jul; 11(1):15039. PubMed ID: 34294814 [TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer. Li F; Zhao Y; Wei L; Li S; Liu J Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia. Salem ML; El-Shanshory MR; Abdou SH; Attia MS; Sobhy SM; Zidan MF; Zidan AA Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):158-167. PubMed ID: 29388481 [TBL] [Abstract][Full Text] [Related]
4. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients. Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288 [TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells and regulatory T cells share common immunoregulatory pathways-related microRNAs that are dysregulated by acute lymphoblastic leukemia and chemotherapy. Labib Salem M; Zidan AA; Ezz El-Din El-Naggar R; Attia Saad M; El-Shanshory M; Bakry U; Zidan M Hum Immunol; 2021 Jan; 82(1):36-45. PubMed ID: 33162185 [TBL] [Abstract][Full Text] [Related]
6. Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma. Siret C; Collignon A; Silvy F; Robert S; Cheyrol T; André P; Rigot V; Iovanna J; van de Pavert S; Lombardo D; Mas E; Martirosyan A Front Immunol; 2019; 10():3070. PubMed ID: 32038621 [TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients. Papadaki MA; Aggouraki D; Vetsika EK; Xenidis N; Kallergi G; Kotsakis A; Georgoulias V Anticancer Res; 2021 Feb; 41(2):661-670. PubMed ID: 33517270 [TBL] [Abstract][Full Text] [Related]
8. Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout. Zhong L; Li S; Wen Y; Zheng J; Liu F; Cao D; Liu Y Front Immunol; 2020; 11():567783. PubMed ID: 33154749 [TBL] [Abstract][Full Text] [Related]
9. Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma. Solórzano JL; Menéndez V; Parra E; Solis L; Salazar R; García-Cosío M; Climent F; Fernández S; Díaz E; Francisco-Cruz A; Khoury J; Jiang M; Tamegnon A; Montalbán C; Melero I; Wistuba I; De Andrea C; F García J Oncoimmunology; 2024; 13(1):2388304. PubMed ID: 39135889 [TBL] [Abstract][Full Text] [Related]
10. Increased regulatory T cells in acute lymphoblastic leukemia patients. Idris SZ; Hassan N; Lee LJ; Md Noor S; Osman R; Abdul-Jalil M; Nordin AJ; Abdullah M Hematology; 2015 Oct; 20(9):523-9. PubMed ID: 26119924 [TBL] [Abstract][Full Text] [Related]
11. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function. Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175 [TBL] [Abstract][Full Text] [Related]
12. Impaired myeloid-derived suppressor cells are associated with recurrent implantation failure: A case-control study. Jiang H; Zhu M; Guo P; Bi K; Lu Z; Li C; Zhai M; Wang K; Cao Y J Reprod Immunol; 2021 Jun; 145():103316. PubMed ID: 33866110 [TBL] [Abstract][Full Text] [Related]
13. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma. Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384 [TBL] [Abstract][Full Text] [Related]
14. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p. Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708 [TBL] [Abstract][Full Text] [Related]
15. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma. Yokota S; Yonezawa T; Momoi Y; Maeda S Vet Immunol Immunopathol; 2024 Mar; 269():110716. PubMed ID: 38308864 [TBL] [Abstract][Full Text] [Related]
16. Sildenafil might impair maternal-fetal immunotolerance by suppressing myeloid-derived suppressor cells in mice. Jiang HH; Wang KX; Bi KH; Lu ZM; Zhang JQ; Cheng HR; Zhang MY; Su JJ; Cao YX J Reprod Immunol; 2020 Nov; 142():103175. PubMed ID: 32682164 [TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress induced LOX-1 Nan J; Xing YF; Hu B; Tang JX; Dong HM; He YM; Ruan DY; Ye QJ; Cai JR; Ma XK; Chen J; Cai XR; Lin ZX; Wu XY; Li X Immunology; 2018 May; 154(1):144-155. PubMed ID: 29211299 [TBL] [Abstract][Full Text] [Related]
18. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling. Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475 [TBL] [Abstract][Full Text] [Related]
20. mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation. Lin Y; Wang B; Shan W; Tan Y; Feng J; Xu L; Wang L; Han B; Zhang M; Yu J; Yu X; Huang H Clin Immunol; 2018 Feb; 187():122-131. PubMed ID: 29132870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]